AMG510 targeted drug is mainly used to treat locally advanced or metastatic non-small cell lung cancer whose tumors carry the KRAS G12C mutation. AMG510 targeted drug is a new type of anticancer therapy, mainly used for the treatment of non-small cell lung cancer that has spread to other parts of the body or cannot be removed by surgery, whose tumor carries the KRAS G12C gene and has received at least one cancer treatment. AMG510 targeted drugs can relieve patients’ symptoms and effectively control the disease, and the main adverse reactions are loss of appetite, diarrhea, fatigue, headache, cough, hot flashes (a bout of fever), nausea, and so on. There is no available data on the use of AMG510 targeted drug in pregnant as well as lactating women, therefore, women who are already pregnant or planning to become pregnant, as well as those who are breastfeeding, should inform their doctors of the specific situation before starting the treatment, and use the drug as appropriate to avoid any adverse consequences. AMG510 targeted drug is a prescription drug and should not be used on its own, and the drug should be used in strict accordance with the doctor’s instructions to avoid adverse consequences.